| Literature DB >> 30053426 |
Leah V Sibener1, Ricardo A Fernandes2, Elizabeth M Kolawole3, Catherine B Carbone4, Fan Liu5, Darren McAffee6, Michael E Birnbaum1, Xinbo Yang2, Laura F Su7, Wong Yu7, Shen Dong2, Marvin H Gee1, Kevin M Jude2, Mark M Davis8, Jay T Groves6, William A Goddard9, James R Heath10, Brian D Evavold3, Ronald D Vale11, K Christopher Garcia12.
Abstract
TCR-signaling strength generally correlates with peptide-MHC binding affinity; however, exceptions exist. We find high-affinity, yet non-stimulatory, interactions occur with high frequency in the human T cell repertoire. Here, we studied human TCRs that are refractory to activation by pMHC ligands despite robust binding. Analysis of 3D affinity, 2D dwell time, and crystal structures of stimulatory versus non-stimulatory TCR-pMHC interactions failed to account for their different signaling outcomes. Using yeast pMHC display, we identified peptide agonists of a formerly non-responsive TCR. Single-molecule force measurements demonstrated the emergence of catch bonds in the activating TCR-pMHC interactions, correlating with exclusion of CD45 from the TCR-APC contact site. Molecular dynamics simulations of TCR-pMHC disengagement distinguished agonist from non-agonist ligands based on the acquisition of catch bonds within the TCR-pMHC interface. The isolation of catch bonds as a parameter mediating the coupling of TCR binding and signaling has important implications for TCR and antigen engineering for immunotherapy.Entities:
Keywords: CD45; MHC; TCR; catch bond; ligand discrimination; molecular dynamics; signaling; structure
Mesh:
Substances:
Year: 2018 PMID: 30053426 PMCID: PMC6140336 DOI: 10.1016/j.cell.2018.06.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582